Iperion remains a NZ$2.1m cash shell with no operations deployed in FY21

It is not an operating result. The entity continued to function as a cash shell, with no trading revenue, only interest income of NZ$0.025m, and a net loss of NZ$0.1m versus a NZ$0.2m loss in FY20. On the canonical computed basis, PBT and NPAT both improved 99.9%, but on trivial absolute dollars. Cash sits at NZ$2.1m, equity at NZ$2.1m, and no dividend was declared. Annolyse's historical baseline confirms the picture: revenue growth of -100.0% is within the company's normal range against a four-period mean of -74.9%, meaning this entity has not generated operating revenue across the available history.

All five like-for-like comparisons are dominated by base effects on very small numbers, and the "revenue" line is interest on the cash float. There is no margin, mix, segment, or working-capital story to read here, and any growth percentage should be treated as accounting arithmetic rather than operating progress.

Issuer transition breaks comparability. The current:issuer_transition overlay and the announcement filed under the SNC banner mean the prior period is not a clean like-for-like baseline for what IPR will become. The interim:acquisition overlay attached to HY21, combined with HY21 commentary about "appropriate acquisition targets with the support of the new majority," tells the reader that the strategic intent is to deploy cash into an acquired business — but FY21 shows no acquisition has yet been completed.

Total assets sit above the historical range. At NZ$2.2m the entity is carrying more on the balance sheet than its four-period mean of NZ$1.3m (range NZ$0.5m–NZ$2.0m), which is consistent with capital having been raised or recycled ahead of a transaction rather than burned on operations. ROE at -5.7% is at the upper edge of the company's historical range (mean -25.4%), again reflecting a smaller loss against a larger equity base, not improving returns.

The HY21 commentary signals intent to acquire but does not set a timeline, valuation envelope, or sector. FY21 therefore does not support a view on when, or into what, the NZ$2.1m cash will be deployed. The gap matters because the entire investment case is contingent on that deployment: until something is acquired, the share is a cash claim plus optionality, and the FY21 result tells the reader nothing about which targets are credible.

The narrower loss is the difference between interest income and listed-entity administrative costs, and operating cash outflow of NZ$0.1m broadly tracks the reported loss. That alignment is not a quality endorsement — it simply confirms there is no working capital, no inventory, no debtors, and no capex pattern to interpret. Cash conversion, debtor days, inventory days, and operating leverage are not meaningful concepts for this filing.

What is durable is the cash balance itself: NZ$2.1m on the balance sheet against an annual admin burn of roughly NZ$0.1m gives the shell multi-year runway to find a transaction. What is not durable is any extrapolation from the percentage improvements in PBT and NPAT; on absolute dollars these movements are immaterial, and Annolyse's historical baseline already classifies four consecutive periods of large positive or near-100% loss-narrowing as the company's normal pattern. The result therefore neither confirms nor undermines the eventual operating thesis — it simply preserves the optionality.

This briefing cannot assess the quality, valuation, or strategic fit of any prospective acquisition because no target has been disclosed in the supplied release.